High Net Worth Advisory Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$27.5K 265
2022
Q4
$27.5K Sell
1,500
-500
-25% -$9.15K 0.01% 395
2022
Q3
$39K Buy
+2,000
New +$39K 0.02% 364